Nexalin Technology (Nexalin Technology) Price-to-Operating-Cash-Flow : (As of Jun. 10, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nexalin Technology Price-to-Operating-Cash-Flow?

As of today (2024-06-10), Nexalin Technology's share price is $0.72. Nexalin Technology's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.45. Hence, Nexalin Technology's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Nexalin Technology's Price-to-Operating-Cash-Flow or its related term are showing as below:

NXL's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 20.73
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Nexalin Technology's Cash Flow from Operations per share for the three months ended in Mar. 2024 was $-0.10. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.45.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -63.60% per year.

During the past 4 years, Nexalin Technology's highest 3-Year average Operating Cash Flow per Share Growth Rate was -63.60% per year. The lowest was -63.60% per year. And the median was -63.60% per year.

Nexalin Technology Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Nexalin Technology's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nexalin Technology Price-to-Operating-Cash-Flow Chart

Nexalin Technology Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Nexalin Technology Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Nexalin Technology's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Nexalin Technology's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nexalin Technology's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nexalin Technology's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Nexalin Technology's Price-to-Operating-Cash-Flow falls into.

Nexalin Technology Price-to-Operating-Cash-Flow Calculation

Nexalin Technology's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.72	/	-0.445
	=

Nexalin Technology's Share Price of today is $0.72.
Nexalin Technology's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.45.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Nexalin Technology Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Nexalin Technology's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Nexalin Technology (Nexalin Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nexalin Technology Inc (NAS:NXL) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

1776 Yorktown, Suite 550, Houston, TX, USA, 77056

Website

https://www.nexalin.com

Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy.

Executives

Marilyn Elson	10 percent owner, officer: Ms. Elson serves as CFO	32 CAMLET COURT, ROSELAND NJ 07068
Rick Morad	director	6331 CHAGRIN RIVER ROAD, BENTLEYVILLE OH 44022
Mark White	director, officer: President/CEO	1776 YORKTOWN STREET, SUITE 550, HOUSTON TX 77056
David Owens	director, officer: Chief Medical Officer	4545 HARRIS TRAIL NW, ATLANTA GA 30327
Alan Kazden	director	3435 CONSUELO DRIVE, CALABASAS CA 91302
Leonard Osser	other: Spouse
Ben Hu	director	7021 EDGERTON ROAD, NORTH ROYALTON OH 44133